Principal Financial Group Inc. grew its stake in Innospec Inc. (NASDAQ:IOSP – Free Report) by 3.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 129,448 shares of the specialty chemicals company’s stock after acquiring an additional 4,376 shares during the period. Principal Financial Group Inc. owned 0.52% of Innospec worth $14,247,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Blue Trust Inc. grew its holdings in shares of Innospec by 503.9% in the 3rd quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock valued at $96,000 after acquiring an additional 650 shares in the last quarter. KBC Group NV lifted its stake in Innospec by 82.3% in the 4th quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company’s stock valued at $136,000 after purchasing an additional 558 shares during the last quarter. Point72 Asset Management L.P. acquired a new stake in Innospec in the 3rd quarter valued at about $215,000. Claro Advisors LLC acquired a new stake in Innospec in the 4th quarter valued at about $220,000. Finally, Raymond James Trust N.A. lifted its stake in Innospec by 7.9% in the 3rd quarter. Raymond James Trust N.A. now owns 2,106 shares of the specialty chemicals company’s stock valued at $238,000 after purchasing an additional 155 shares during the last quarter. Institutional investors own 96.64% of the company’s stock.
Innospec Stock Performance
Shares of NASDAQ:IOSP opened at $103.57 on Thursday. Innospec Inc. has a 52-week low of $99.49 and a 52-week high of $133.71. The company has a market capitalization of $2.59 billion, a P/E ratio of 72.94 and a beta of 1.09. The company has a 50-day simple moving average of $110.29 and a 200 day simple moving average of $112.31.
Insiders Place Their Bets
In other Innospec news, SVP Corbin Barnes sold 598 shares of the firm’s stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $103.06, for a total transaction of $61,629.88. Following the completion of the sale, the senior vice president now directly owns 8,051 shares in the company, valued at $829,736.06. This trade represents a 6.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Philip John Boon sold 3,754 shares of the firm’s stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $103.30, for a total transaction of $387,788.20. Following the sale, the vice president now owns 20,079 shares of the company’s stock, valued at $2,074,160.70. This trade represents a 15.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,696 shares of company stock worth $794,853 over the last three months. Insiders own 1.52% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded shares of Innospec from a “buy” rating to a “hold” rating in a research note on Wednesday.
View Our Latest Stock Analysis on Innospec
Innospec Profile
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Read More
- Five stocks we like better than Innospec
- What is Short Interest? How to Use It
- Buffett’s on the Sidelines – Should You Follow?
- Market Cap Calculator: How to Calculate Market Cap
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.